Anti-osteoporotic treatment and COVID-19 risk: is there an association?
Introduction. Despite the recent ASBMR, AACE, Endocrine Society, ECTS&NOF guidelines for osteoporosis management in the era of COVID-19 the impact of antiosteoporotic drugs on disease risk and severity is insufficiently studied. The purpose of this study was to assess the COVID-19 risk for the p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2022-06-01
|
| Series: | Bolʹ, Sustavy, Pozvonočnik |
| Subjects: | |
| Online Access: | https://pjs.zaslavsky.com.ua/index.php/journal/article/view/328 |